It has been shown that the activation of the MAPK/ERK pathway is closely associated with the invasion and migration, proliferation, drug resistance, and glycolysis in HCC (Liet al., 2020a; Li et al., 2020b; He et al., 2020). Here, MAPK1 is linked to hepatocellular carcinoma.